Nikolaos Grigoriadis

Author

Aristotle University of Thessaloniki ORCID

Also Known As

Chris H Polman, Grigoriadis Nikolaos, Grigoriadis, Nikolaos, N Grigoriadis, N. Grigoriadis, Nikolaos C Grigoriadis, Nikolaos C. Grigoriadis, Nikolaos Grigoriadis, Orla Gray, Stella Hughes

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Aristotle University of Thessaloniki AHEPA University Hospital The Royal Melbourne Hospital Inserm St. Josef-Hospital

About

Nikolaos Grigoriadis is an author at Aristotle University of Thessaloniki specializing in medicine, neuroimmunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.5K
2	Health Sciences	3	3	925
3	Biomedical Engineering	2	2	72
4	Biostatistics	1	1	24
5	Blood Transplantation	1	1	24

Nikolaos Grigoriadis

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Ludwig Kappos, Amit Bar‐Or, Bruce Cree, The Lancet Neurological DisorderClinical NeurologyClinical TrialsSiponimod Versus PlaceboNeurological Monitoring	2018	896
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring Ludwig Kappos, David O. Bates, Gilles Edan, The Lancet Neurology Translational MedicineSystemic SclerodermaMedicineImmunologyClinical Trials	2011	265
Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS Robert J. Fox, Andrew Chan, Ralf Gold, Neurology Clinical Practice	2016	104
Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies Gidon Karmon, Shlomo Sragovich, Gal Hacohen-Kleiman, Biological Psychiatry Knockout MouseNeurodegenerative DiseasesDevelopmental BiologyMolecular NeuroscienceMendelian Disorder	2021	74
Efficacy of a Computer-Assisted Cognitive Rehabilitation Intervention in Relapsing-Remitting Multiple Sclerosis Patients: A Multicenter Randomized Controlled Trial Lambros Messinis, Grigorios Nasios, Mary H. Kosmidis, Behavioural Neurology	2017	60
Effectiveness of protocol for the isolation of Wharton’s Jelly stem cells in large-scale applications Anastasia Petsa, Sofia Gargani, Antigonos Felesakis, In Vitro Cellular & Developmental Biology - Animal MedicineStem CellsAdult Stem CellWharton ’Stem Cell Research	2009	56
Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma Apostolos Karakolios, Christos Kasapis, Theofilos Kallinikidis, Clinical Gastroenterology and Hepatology UrologyHepatologyBiliary TractSurgical PathologyHistopathology	2003	55
Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome David Tanné, Aviva Katzav, Orit Beilin, Neurobiology of Disease InflammationThrombosisAnti-inflammatoryCardiovascular DiseaseBlood Platelet	2008	47
Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Athanasios Lourbopoulos, Experimental Neurology Autoimmune DiseaseMedicineImmunologyAutophagyAutoimmunity	2006	46
Immunomodulation of EAE by alpha-fetoprotein involves elevation of immune cell apoptosis markers and the transcription factor FoxP3 Michal Irony-Tur-Sinai, Nikolaos Grigoriadis, Dimitrios Tsiantoulas, Journal of the Neurological Sciences Alpha-fetoprotein Involves ElevationImmunogeneticsAutoimmune DiseaseApoptosisAutophagy	2009	29

Page 1